Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Statistics in Medicine|February 25, 2020
A robust Bayesian mixed effects approach for zero inflated and highly skewed longitudinal count data emanating from the zero inflated discrete Weibull distributionDivan Aristo Burger, Robert Schall, Johannes Theodorus Ferreira, et al.
British Journal of Clinical Pharmacology|February 11, 2011
The DPP-4 inhibitor linagliptin does not prolong the QT interval at therapeutic and supratherapeutic dosesArne Ring, Andreas Port, E Ulrike Graefe-Mody, et al.
Clinical Drug Investigation|July 1, 2011
Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose studyChristian Friedrich, Andreas Port, Arne Ring, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 24, 2014
Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trialsKatrin Metzmann, David Schnell, Arvid Jungnik, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Pharmacokinetics of linagliptin in subjects with hepatic impairmentUlrike Graefe-Mody, Peter Rose, Silke Retlich, et al.
Trials|March 20, 2014
Evaluation of a tailored intervention to improve management of overweight and obesity in primary care: study protocol of a cluster randomised controlled trialJane Krause, Shona Agarwal, Danielle H Bodicoat, et al.
Implementation Science : IS|May 29, 2016
Cluster randomised trial of a tailored intervention to improve the management of overweight and obesity in primary care in EnglandJane Goodfellow, Shona Agarwal, Fawn Harrad, et al.
Trials|November 23, 2015
A randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer: report on a pilot and feasibility studyDavid J Bowrey, Melanie Baker, Vanessa Halliday, et al.
Cardiovascular Diabetology|April 27, 2013
The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) studyArne Ring, Tobias Brand, Sreeraj Macha, et al.
Clinical Pharmacokinetics|November 9, 2010
Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjectsSilke Retlich, Vincent Duval, Arne Ring, et al.
Pageof 6